{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:44:46Z","timestamp":1775904286661,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["R01MH114562-01"],"award-info":[{"award-number":["R01MH114562-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1161471"],"award-info":[{"award-number":["OPP1161471"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["MR\/R015600\/1"],"award-info":[{"award-number":["MR\/R015600\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>HIV incidence in adolescent girls and young women remains high in sub-Saharan Africa. Progress towards uptake of HIV prevention methods remains low. Studies of oral pre-exposure prophylaxis (PrEP) have shown that uptake and adherence may be low due to low-risk perception and ambivalence around using antiretrovirals for prevention. No evidence exists on whether an interactive intervention aimed at adjusting risk perception and addressing the uncertainty around PrEP will improve uptake. This pilot research trial aims to provide an initial evaluation of the impact of an interactive digital tablet-based counselling session, correcting risk perception, and addressing ambiguity around availability, usability, and effectiveness of PrEP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods\/Design<\/jats:title><jats:p>This is a matched-cluster randomized controlled trial which will compare an interactive tablet-based education intervention against a control with no intervention. The study will be implemented in eight sites. In each site, two matched clusters of villages will be created. One cluster will be randomly allocated to intervention. In two sites, a community engagement intervention will also be implemented to address social obstacles and to increase support from peers, families, and social structures.\u00a0A total of 1200 HIV-negative young women aged 18\u201324\u2009years, not on PrEP at baseline, will be eligible. Baseline measures of endpoints will be gathered in surveys. Follow-up assessment at six months will include biomarkers of PrEP uptake and surveys.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This will be the first randomized controlled trial to determine whether interactive feedback counselling leads to uptake of HIV prevention methods such as PrEP and reduces risky sexual behavior. If successful, policymakers could consider such an intervention in school-based education campaigns or as post-HIV-testing counselling for young people.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>Clinicaltrials.gov,<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03565575\">NCT03565575<\/jats:ext-link>. Registered on 21 June 2018.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13063-019-3791-8","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T14:06:14Z","timestamp":1575295574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Improving risk perception and uptake of pre-exposure prophylaxis (PrEP) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomized trial"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-4574","authenticated-orcid":false,"given":"Ranjeeta","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Skovdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo M.","family":"Galizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louisa","family":"Moorhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"Nyamukapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rufurwokuda","family":"Maswera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis","family":"Mandizvidza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy B.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Gregson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"3791_CR1","volume-title":"Women and HIV: A spotlight on adolescent girls and young women","author":"UNAIDS","year":"2019","unstructured":"UNAIDS. Women and HIV: A spotlight on adolescent girls and young women. Geneva: UNAIDS; 2019."},{"key":"3791_CR2","volume-title":"Political declaration on HIV and AIDS: on the fast track to accelerate the fight against HIV and to end the AIDS epidemic by 2030. A\/70\/L.52","author":"United Nations General Assembly","year":"2016","unstructured":"United Nations General Assembly. Political declaration on HIV and AIDS: on the fast track to accelerate the fight against HIV and to end the AIDS epidemic by 2030. A\/70\/L.52. Geneva: United Nations; 2016."},{"key":"3791_CR3","volume-title":"Extended Zimbabwe National HIV and AIDS Strategic Plan 2015\u20132020","author":"National AIDS Council, Ministry of Health and Childcare","year":"2015","unstructured":"National AIDS Council, Ministry of Health and Childcare. Extended Zimbabwe National HIV and AIDS Strategic Plan 2015\u20132020. Harare: National AIDS Council; 2015."},{"key":"3791_CR4","volume-title":"Prevention Gap Report","author":"UNAIDS","year":"2016","unstructured":"UNAIDS. Prevention Gap Report. Geneva: UNAIDS; 2016."},{"issue":"9","key":"3791_CR5","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1016\/S2352-3018(16)30115-1","volume":"3","author":"S Mathur","year":"2016","unstructured":"Mathur S, Pilgrim N, Pulerwitz J. PrEP introduction for adolescent girls and young women. Lancet HIV. 2016;3(9):e406\u2013e8.","journal-title":"Lancet HIV"},{"key":"3791_CR6","volume-title":"Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP)","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Geneva: WHO; 2015."},{"issue":"3 Suppl 2","key":"3791_CR7","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.7448\/IAS.17.3.19146","volume":"17","author":"A van der Straten","year":"2014","unstructured":"van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET, et al. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. J Int AIDS Soc. 2014;17(3 Suppl 2):19146.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"3791_CR8","doi-asserted-by":"publisher","first-page":"e0125458","DOI":"10.1371\/journal.pone.0125458","volume":"10","author":"A Corneli","year":"2015","unstructured":"Corneli A, Perry B, Agot K, Ahmed K, Malamatsho F, Van Damme L. Facilitators of adherence to the study pill in the FEM-PrEP clinical trial. PLoS One. 2015;10(4):e0125458.","journal-title":"PLoS One"},{"key":"3791_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jebo.2015.02.020","volume":"118","author":"S Datta","year":"2015","unstructured":"Datta S, Burns J, Maughan-Brown B, Darling M, Eyal K. Risking it all for love? Resetting beliefs about HIV risk among low-income South African teens. J Econ Behav Organ. 2015;118:184\u201398.","journal-title":"J Econ Behav Organ"},{"issue":"1","key":"3791_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1257\/app.3.1.1","volume":"3","author":"P Dupas","year":"2011","unstructured":"Dupas P. Do Teenagers Respond to HIV Risk Information? Evidence from a Field Experiment in Kenya. Am Econ J Appl Econ. 2011;3(1):1\u201334.","journal-title":"Am Econ J Appl Econ"},{"key":"3791_CR11","unstructured":"Born P. Community conversations: Mobilizing the ideas, skills, and passion of community organizations, governments, businesses, and people. Toronto: BPS Books; 2012."},{"key":"3791_CR12","volume-title":"Upscaling Community Conversations in Ethiopia 2004 : unleashing capacities of communities for the HIV\/AIDS response","author":"UNDP","year":"2004","unstructured":"UNDP. Upscaling Community Conversations in Ethiopia 2004 : unleashing capacities of communities for the HIV\/AIDS response. Addis Ababa: UNDP; 2004."},{"key":"3791_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jpba.2013.08.033","volume":"88","author":"J-H Zheng","year":"2014","unstructured":"Zheng J-H, Guida LA, Rower C, Castillo-Mancilla J, Meditz A, Klein B, et al. Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS\/MS. J Pharm Biomed Anal. 2014;88:144\u201351.","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"3791_CR14","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893\u2013907.","journal-title":"Qual Quant"},{"issue":"3 February 2006","key":"3791_CR15","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.1121054","volume":"311","author":"S Gregson","year":"2006","unstructured":"Gregson S, Garnett GP, Nyamukapa CA, Hallett TB, Lewis JJC, Mason PR, et al. HIV decline associated with behaviour change in eastern Zimbabwe. Science. 2006;311(3 February 2006):664\u20136.","journal-title":"Science"},{"key":"3791_CR16","volume-title":"ANC Surveillance Report 2012","author":"Zimbabwe Ministry of Health and Child Welfare","year":"2013","unstructured":"Zimbabwe Ministry of Health and Child Welfare. ANC Surveillance Report 2012. Harare: Zimbabwe Ministry of Health and Child Welfare; 2013."},{"issue":"9879","key":"3791_CR17","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(13)60685-6","volume":"381","author":"A Prost","year":"2013","unstructured":"Prost A, Colbourn T, Seward N, Azad K, Coomarasamy A, Copas A, et al. Women\u2019s groups practising participatory learning and action to improve maternal and newborn health in low-resource settings: a systematic review and meta-analysis. Lancet. 2013;381(9879):1736\u201346.","journal-title":"Lancet"},{"key":"3791_CR18","volume-title":"Partners in planning: information, participation and empowerment","author":"S Rifkin","year":"2001","unstructured":"Rifkin S, Pridmore P. Partners in planning: information, participation and empowerment. London: Macmillan; 2001."},{"issue":"9879","key":"3791_CR19","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(12)61959-X","volume":"381","author":"S Lewycka","year":"2013","unstructured":"Lewycka S, Mwansambo C, Rosato M, Kazembe P, Phiri T, Mganga A, et al. Effect of women\u2019s groups and volunteer peer counselling on rates of mortality, morbidity, and health behaviours in mothers and children in rural Malawi (MaiMwana): a factorial, cluster-randomised controlled trial. Lancet. 2013;381(9879):1721\u201335.","journal-title":"Lancet"},{"issue":"9721","key":"3791_CR20","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(09)62042-0","volume":"375","author":"P Tripathy","year":"2010","unstructured":"Tripathy P, Nair N, Barnett S, Mahapatra R, Borghi J, Rath S, et al. Effect of a participatory intervention with women\u2019s groups on birth outcomes and maternal depression in Jharkhand and Orissa, India: a cluster-randomised controlled trial. Lancet. 2010;375(9721):1182\u201392.","journal-title":"Lancet"},{"issue":"9438","key":"3791_CR21","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0140-6736(04)17021-9","volume":"364","author":"DS Manandhar","year":"2004","unstructured":"Manandhar DS, Osrin D, Shrestha BP, Mesko N, Morrison J, Tumbahangphe KM, et al. Effect of a participatory intervention with women\u2019s groups on birth outcomes in Nepal: cluster-randomised controlled trial. Lancet. 2004;364(9438):970\u20139.","journal-title":"Lancet"},{"issue":"8","key":"3791_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/jech-2015-206665","volume":"70","author":"T Abramsky","year":"2016","unstructured":"Abramsky T, Devries KM, Michau L, Nakuti J, Musuya T, Kyegombe N, et al. The impact of SASA!, a community mobilisation intervention, on women\u2019s experiences of intimate partner violence: secondary findings from a cluster randomised trial in Kampala, Uganda. J Epidemiol Community Health. 2016;70(8):818\u201325.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"3791_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-13-1","volume":"13","author":"C Campbell","year":"2013","unstructured":"Campbell C, Nhamo M, Scott K, Madanhire C, Nyamukapa C, Skovdal M, et al. The role of community conversations in facilitating local HIV competence: case study from rural Zimbabwe. BMC Public Health. 2013;13(1):1.","journal-title":"BMC Public Health"},{"issue":"2","key":"3791_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1728-4457.2011.00413.x","volume":"37","author":"S Gregson","year":"2011","unstructured":"Gregson S, Mushati P, Grusin H, Nhamo M, Schumacher C, Skovdal M, et al. Social capital and reduced female vulnerability to HIV infection in rural Zimbabwe. Popul Dev Rev. 2011;37(2):333\u201359.","journal-title":"Popul Dev Rev"},{"issue":"7","key":"3791_CR25","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1016\/S2352-3018(16)30039-X","volume":"3","author":"GP Garnett","year":"2016","unstructured":"Garnett GP, Hallett TB, Takaruza A, Hargreaves J, Rhead R, Warren M, et al. Providing a conceptual framework for HIV prevention cascades and assessing the feasability of empirical measurement with data from east Zimbabwe. Lancet HIV. 2016;3(7):e297\u2013306.","journal-title":"Lancet HIV"},{"issue":"1","key":"3791_CR26","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/S2352-3018(18)30327-8","volume":"6","author":"R Schaefer","year":"2019","unstructured":"Schaefer R, Gregson S, Fearon E, Hensen B, Hallett TB, Hargreaves JR. HIV prevention cascades: a unifying framework to replicate the successes of treatment cascades. Lancet HIV. 2019;6(1):e60\u2013e6.","journal-title":"Lancet HIV"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3791-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3791-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3791-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:40:26Z","timestamp":1695480026000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3791-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3791"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3791-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"28 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As described above, this study has been approved by\u00a0the Medical Research Council of Zimbabwe (Ref. MRCZ\/A\/2243), Biomedical Research and Training Institute Zimbabwe Institutional Review Board (Ref. AP140\/2017), and the Imperial College London Research Ethics Committee (Ref. 17IC4160). Each participant will provide written informed consent before the initiation of baseline assessments or the intervention.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SG declares shares in GlaxoSmithKline and AstraZeneca. TBH declares grants outside the subject area from: UNAIDS, WHO, BMGF, MRC. RT declares grants outside the subject area from EDCTP. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"668"}}